Nasal and systemic interleukin-1β and interleukin-3 in chronic obstructive pulmonary disease: association with upper airway symptom burden rather than with disease severity
Nermen M. Abuelkassem, Entsar H. Mohamed, Eman Radwan, Maha Ali, Ahmed Elrahman Mohamed Azzam, Hend M. Sayed
Springer Nature ·
2026-11-07
· DOI 10.1186/s12890-026-04712-2
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Nermen M. Abuelkassem, Entsar H. Mohamed, Eman Radwan, Maha Ali, Ahmed Elrahman Mohamed Azzam, Hend M. Sayed. Nasal and systemic interleukin-1β and interleukin-3 in chronic obstructive pulmonary disease: association with upper airway symptom burden rather than with disease severity. // BMC Pulmonary Medicine. – 2026. – DOI: 10.1186/s12890-026-04712-2. – URL: https://doi.org/10.1186/s12890-026-04712-2
Nermen M. Abuelkassem, Entsar H. Mohamed, Eman Radwan, Maha Ali, Ahmed Elrahman Mohamed Azzam, & Hend M. Sayed (2026). Nasal and systemic interleukin-1β and interleukin-3 in chronic obstructive pulmonary disease: association with upper airway symptom burden rather than with disease severity. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-026-04712-2
Nermen M. Abuelkassem, et al. “Nasal and systemic interleukin-1β and interleukin-3 in chronic obstructive pulmonary disease: association with upper airway symptom burden rather than with disease severity.” BMC Pulmonary Medicine, 2026. doi:10.1186/s12890-026-04712-2.
@article{Abuelkassem2026,
title = {Nasal and systemic interleukin-1β and interleukin-3 in chronic obstructive pulmonary disease: association with upper airway symptom burden rather than with disease severity},
author = {Abuelkassem, Nermen M. and Mohamed, Entsar H. and Radwan, Eman and Ali, Maha and Azzam, Ahmed Elrahman Mohamed and Sayed, Hend M.},
journal = {BMC Pulmonary Medicine},
year = {2026},
doi = {10.1186/s12890-026-04712-2},
url = {https://doi.org/10.1186/s12890-026-04712-2}
}